Search projects

Examples: APPROACH

34 projects found

IDEA-FAST

Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases

Keywords: IMI projects Neurodegenerative diseases Autoimmune diseases Clinical trial design Digital health Real-world data, evidence

17

INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.

Keywords: IMI projects Diabetes & metabolic disorders Clinical trial design Disease taxonomy

18

INNODIA HARVEST

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Keywords: IMI projects Diabetes & metabolic disorders Clinical trial design Conducting clinical trials Disease taxonomy

19

ND4BB

New Drugs for Bad Bugs. Umbrella programme comprising the IMI projects TRANSLOCATION, ENABLE, COMBACTE-NET, COMBACTE-CARE, COMBACTE-MAGNET, COMBACTE-CDI, iABC and DRIVE-AB

Keywords: IMI projects Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Clinical networks Real-world data, evidence Drug discovery Economic model

20

NECESSITY

New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients

Keywords: IMI projects Autoimmune diseases Tools for predicting/monitoring efficacy Clinical trial design Disease taxonomy

21

NEWMEDS

Novel methods leading to new medications in depression and schizophrenia

Keywords: IMI projects Psychiatric diseases Tools for predicting/monitoring safety Clinical trial design Drug discovery

22

PARADIGM

Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes

Keywords: IMI projects Clinical trial design Patient involvement in R&D Regulatory and HTA processes

23

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle

Keywords: IMI projects Clinical trial design Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

24